| CUE BIOPHARM.INC. DL-,001 |
| USA |
| Gesundheit |
| US22978P1066 / A2JAT5 |
| 1UC (Frankfurt) / CUE (NASDAQ) |
| FRA:1UC, ETR:1UC, 1UC:GR, NASDAQ:CUE |
| - |
| https://www.cuebiopharma... |
|
Cue Biopharma Inc. is a biotechnology company focused on developing innovative biologic drugs that can precisely modulate the human immune system. The company's primary purpose is to create therapies that can selectively enhance or inhibit immune res..
>Volltext.. |
| 14.8 Mio. EUR |
| -4.5 Mio. EUR |
| 23.52 Mio. EUR |
| -19.06 Mio. EUR |
| -22.78 Mio. EUR |
| -0.27 EUR |
| 3.59 Mio. EUR |
| 23.24 Mio. EUR |
| -18.57 Mio. EUR |
| 2.01 |
| 160.67% |
| 42.35% |
| - |
| - |
| - |
| - |
| CUE BIOPHARMA |
| 09.04.26 |
|